Pharma Focus Asia

Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

Golidocitinib Receives Approval in China as the First JAK1-Selective Inhibitor for Treating Relapsed or Refractory Peripheral T-Cell Lymphoma

Thursday, June 20, 2024

Dizal a biopharmaceutical company dedicated to developing new treatments for cancer and immunological diseases announced that golidocitinib has received approval from the National Medical Products

Roche Launches New Test for Early Detection of B-cell Lymphoma

Thursday, June 20, 2024

Roche has recently launched the VENTANA Kappa and Lambda Dual ISH mRNA Probe Cocktail assay the first ISH test approved for clinical use in countries that accept the CE Mark This assay aids pathologists in distinguishing between Bcell malignancies an...

GenFleet Receives IND Approval from China’s NMPA for GFH375, an Oral KRAS G12D (ON/OFF) Inhibitor, to Initiate Phase I/II Clinical Trials in Patients with Advanced Solid Tumors

Thursday, June 20, 2024

GenFleet Therapeutics a biotech company in the clinical stage focusing on advanced therapies for cancer

Spyre Therapeutics Initiates Phase 1 Study of SPY001, a Novel Antibody Targeting α4β7 for Inflammatory Bowel Disease Therapy

Wednesday, June 19, 2024

Spyre Therapeutics Inc a biotechnology firm focused on the development of innovative treatments for Inflammatory Bowel Disease has announced the initiation of its first clinical trial

Ionis and Otsuka Expand Licensing Agreement for Hereditary Angioedema Drug Donidalorsen in Asia Pacific

Wednesday, June 19, 2024

Ionis Pharmaceuticals Inc has finalized a licensing agreement with Otsuka Pharmaceutical Co Ltd granting Otsuka exclusive rights to donidalorsen in the AsiaPacific region

Junshi Biosciences Gains Approval for sNDA of Toripalimab as First-Line Therapy for Small Cell Lung Cancer

Wednesday, June 19, 2024

Shanghai Junshi Biosciences Co Ltd a leading biopharmaceutical company focused on developing innovative therapies announced that the National Medical Products

ReviR Therapeutics and Asieris Pharmaceuticals Reach Milestone in RNA-Targeted Cancer Therapy Development

Tuesday, June 18, 2024

ReviR Therapeutics a biotechnology firm focused on creating small molecule RNA splicing modulators for neurogenetic diseases and cancer and Asieris Pharmaceuticals a global leader in developing

Northwest Biotherapeutics Acquires Exclusive Rights to Dendritic Cell Technology Suite

Tuesday, June 18, 2024

Northwest Biotherapeutics a biotechnology company focused on DCVax personalized immune therapies for solid tumor cancers announced on June that it has acquired

FDA Approves Phase II Study of Ruxoprubart for ANCA-Associated Vasculitis

Tuesday, June 18, 2024

NovelMed is pleased to announce that Ruxoprubart an experimental drug has received approval from the US Food and Drug Administration FDA to initiate a clinical trial focused on patients with ANCA Associated Vasculitis AAV is a rare autoimmune disorde...

Imfinzi, in Combination With Chemotherapy, Has Received Approval in the US for Treating Advanced or Recurrent Endometrial Cancer With Mismatch Repair Deficiency

Monday, June 17, 2024

AstraZenecas Imfinzi has received FDA approval in the United States for the treatment of adult patients

magazine-slider-image
magazine-slider-image
Cytiva - Supor Prime filtersMFA + MMA 2024CPHI China || PMEC China 2024Asia Healthcare Week 2024CPHI Korea 2024CHEMICAL INDONESIA 2024World Orphan Drug Congress Europe 2024INALAB 2024Thermo Fisher - Drug Discovery and the impact of mAbsAdvanced Therapies USA 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals Conference3rd World ADC Asia 2024LogiPharma Asia 2024